TP53 and hepatocellular carcinoma: At present, the VEGF signalling pathway is widely used in the immunotherapy of HCC [75] and may be involved in cell proliferation, growth and apoptosis processes as well as the regulation of the PPAR and TP53 signalling pathways [76].